Qualitest recalls hydrocodone bitartrate and acetaminophen tablets

Qualitest recalls hydrocodone bitartrate and acetaminophen tablets
Qualitest recalls hydrocodone bitartrate and acetaminophen tablets

Qualitest has issued a nationwide voluntary recall of one lot of hydrocodone bitartrate and acetaminophen 10mg/500mg tablets due to potentially oversized tablets.  

The drug maker commenced the recall as a precautionary measure due to the possibility that tablets from lot number C1440512A (exp. date 12/2013) exceed the weight specification and contain potent doses of hydrocodone bitartrate and acetaminophen.

The affected pills are approximately 16.51 mm in length, pink, capsule-shaped tablets, with “3600” debossed on one side of the tablet and “V” on the other, Qualitest said in a press release. The affected lot was distributed between May 14 and August 3, 2012 to wholesale distributors and retail pharmacies nationwide. The lot number can be found on the side of the manufacturer's bottle.

Unintentional administration of tablets with increased acetaminophen content could result in liver toxicity, especially in patients taking other acetaminophen-containing medications, patients with liver dysfunction or those who consume more than three alcoholic beverages a day.

Hydrocodone bitartrate and acetaminophen 10mg/500mg tablets are indicated for the relief of moderate to moderately severe pain.

For more information call (800) 444-4011 or visit www.qualitestrx.com.

More in Web Exclusives

Restless legs syndrome linked to higher mortality in men

Restless legs syndrome linked to higher mortality in ...

Study shows a significant correlation between men with restless legs syndrome and mortality.

Challenges to CCHD pulse oximetry screening identified

Challenges to CCHD pulse oximetry screening identified

Healthcare providers have experienced a number of challenges implementing CCHD pulse oximetry screening for newborns, since the procedure was officially recommended in October 2010.

Rotarix just as effective as Rotateq against rotavirus

Rotarix just as effective as Rotateq against rotavirus

The monovalent rotavirus vaccine is more than 90% effective at preventing rotavirus, putting the vaccine's efficacy on par with the pentavalent vaccine.